Netramark Holdings Inc (TSE:AIAI) has released an update.
NetraMark Holdings Inc. has showcased its NetraAI technology’s breakthrough in identifying Parkinson’s disease (PD) subtypes and crucial disease pathways at the AD/PD™ 2024 conference. Leveraging a dataset from the Michael J. Fox Foundation, NetraAI revealed genetic markers and immune system links that could transform PD diagnosis and treatment. These findings not only enhance the understanding of PD but also have implications for other neurodegenerative disorders, potentially accelerating the development of new therapies.
For further insights into TSE:AIAI stock, check out TipRanks’ Stock Analysis page.
